Grifols completes development of molecular test to detect SARS-CoV-2 virus
Catalan Economy
06 May 2020
“Having sufficient molecular test capacity is critical to helping control this pandemic, and having a high-sensitivity test to handle a possible ‘pooling’ strategy is, without a doubt, a differentiating factor, which could make it feasible,” said Victor Grifols Deu, Grifols co-CEO in the company’s press release.
Grifols began developing its test to detect SARS-CoV-2 the first week of February, through its teams in San Diego, Bilbao and Barcelona.
Source: Grifols
Related News and Success stories.
-
21 Jul 2025
See more Barcelona's Exponential Day 2025: Vanessa Cann unveils the next AI revolutionBarcelona's Exponential Day 2025: Vanessa Cann unveils the next AI revolution
-
18 Jul 2025
See more Catalonia moves up as a Strongly Innovative European Region and leads SpainCatalonia moves up as a Strongly Innovative European Region and leads Spain
-
17 Jul 2025
See more Grifols invests €160 million in Barcelona and creates 400 jobs with a new plasma fractionation plantGrifols invests €160 million in Barcelona and creates 400 jobs with a new plasma fractionation plant
-
16 Jul 2025
See more Meet the 10 most disruptive companies in Catalonia in 2025Meet the 10 most disruptive companies in Catalonia in 2025
